| 000 | 01420 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250515044849.0 | ||
| 264 | 0 | _c20070521 | |
| 008 | 200705s 0 0 eng d | ||
| 022 | _a0269-2813 | ||
| 024 | 7 |
_a10.1111/j.1365-2036.2006.03137.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMorocutti, A | |
| 245 | 0 | 0 |
_aAn open-label study of rabeprazole in patients with Zollinger-Ellison syndrome or idiopathic gastric acid hypersecretion. _h[electronic resource] |
| 260 |
_bAlimentary pharmacology & therapeutics _cNov 2006 |
||
| 300 |
_a1439-44 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a2-Pyridinylmethylsulfinylbenzimidazoles _xadministration & dosage |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntacids _xadministration & dosage |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGastric Acid _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRabeprazole |
| 650 | 0 | 4 |
_aZollinger-Ellison Syndrome _xdrug therapy |
| 700 | 1 | _aMerrouche, M | |
| 700 | 1 | _aBjaaland, T | |
| 700 | 1 | _aHumphries, T | |
| 700 | 1 | _aMignon, M | |
| 773 | 0 |
_tAlimentary pharmacology & therapeutics _gvol. 24 _gno. 10 _gp. 1439-44 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2036.2006.03137.x _zAvailable from publisher's website |
| 999 |
_c16654962 _d16654962 |
||